Oncology Stewardship Pharmacist

Overview

The Oncology Stewardship Pharmacist is responsible for oncology formulary management including onboarding new agents including determination of site of care (inpatient, outpatient, regional campuses); oversight of the review process for off-label, non-formulary or other non-standard use of antineoplastic agents and collaboration with pharmacy IS teams on development and revision EHR resources. The oncology stewardship pharmacist will also participate in the promotion of appropriate antineoplastic utilization through staff education and monitoring of antineoplastic use practices.

Located in Boston and the surrounding communities, Dana-Farber Cancer Institute is a leader in life changing breakthroughs in cancer research and patient care. We are united in our mission of conquering cancer, HIV/AIDS, and related diseases. We strive to create an inclusive, diverse, and equitable environment where we provide compassionate and comprehensive care to patients of all backgrounds, and design programs to promote public health particularly among high-risk and underserved populations. We conduct groundbreaking research that advances treatment, we educate tomorrow's physician/researchers, and we work with amazing partners, including other Harvard Medical School-affiliated hospitals.

PRIMARY DUTIES AND RESPONSIBILITIES:

• Coordinate the onboarding of new antineoplastic medications including formulary process, IS process and operations by ensuring a medication follows all the necessary steps from formulary request by a DFCI provider through pharmacy IS and COE builds and staff education and implementation with nursing and pharmacy teams.
• Ensure standardization of medication onboarding new drugs and implementation of antineoplastic related guidelines across all DFCI sites where appropriate.
• Participate in OSL medication standardization work group to ensure DFCI representation in clinical, IS and operational decision making and participate in implementation of build changes through the active patient management process and promotion of clinical support tools where appropriate.
• Review provider requests for exception orders and evaluate for compendia or literature support to guide the prior authorization process.
• Contribute to the development and maintenance of policies and procedures to support the safe use of antineoplastic medications across all DFCI sites and promote and enhance patient outcomes through safe, effective, cost-efficient, and appropriate medication therapy use for patients receiving antineoplastic therapy.
• Contribute to the institution’s antineoplastic stewardship program through compiling data and metrics on antineoplastic use in the ambulatory setting and reporting data and finding to relevant stakeholders.
• Build and maintain databases and dashboards that support the work of the Antineoplastic Stewardship Program as required.
• Collaborate with the Department of Quality and Patient Safety in the assessment, mitigation and dissemination of antineoplastic-related safety initiatives.
• Coordinate, facilitate, and promote education, training, competency assessment and performance improvement of pharmacists, pharmacy residents and other healthcare professionals in the appropriate use of antineoplastics.
• Collaborate with other disciplines to develop and implement best practices across the institute related to antineoplastic utilization.

MINIMUM JOB QUALIFICATIONS:

The Oncology Stewardship Pharmacist must meet the following requirements to be hired and maintain their position in the Pharmacy Department at DFCI.

Minimum Education:

All Pharmacists require a Bachelor of Science in Pharmacy or Doctor of Pharmacy degree from an accredited college of Pharmacy.

Minimum Experience:

5 years of clinical pharmacy experience with 4 years in oncology required. Oncology Residency preferred.

License/Certification/Registration:

Must be licensed to practice pharmacy in the Commonwealth of Massachusetts. An advanced degree related o specialty practice or Board of Pharmaceutical Specialties or other relevant certification. Must complete 20 continuing education credits per year to maintain licensure.

KNOWLEDGE, SKILLS, AND ABILITIES REQUIRED:

• Ability to effectively communicate both orally and in writing with others inside and outside the department (i.e. patients, providers, other institutions).
• Ability to effectively work and provide appropriate leadership within a collaborative team-focused environment.
• Demonstrated proficiency in the use of technology required to perform primary job functions.
• Ability to prioritize and adapt to changes; accepts additional responsibilities based on the changing needs of the work setting.
• Demonstrated ability to work independently, prioritize and organize work.
• Proven leadership, management and team-building skills.
• Demonstrated critical thinking skills (ability to analyze information objectively and make a reasoned judgement); demonstrated success in developing and implementing appropriate responses to complex emergent/urgent issues, including ability to identify issues for appropriate and sensitive escalation.
• Ability to resolve complex problems within their scope of practice and to escalate appropriately when needed.
• Demonstrated ability to establish and implement a comprehensive regulatory oversight and outreach program in a complex organizational structure.
• Proficient in Microsoft Office Suite (Word, Excel, Outlook and PowerPoint).

SUPERVISORY RESPONSIBILITIES:

None

PATIENT CONTACT:

Yes

At Dana-Farber Cancer Institute, we work every day to create an innovative, caring, and inclusive environment where every patient, family, and staff member feels they belong. As relentless as we are in our mission to reduce the burden of cancer for all, we are committed to having faculty and staff who offer multifaceted experiences. Cancer knows no boundaries and when it comes to hiring the most dedicated and compassionate professionals, neither do we. If working in this kind of organization inspires you, we encourage you to apply.

Dana-Farber Cancer Institute is an equal opportunity employer and affirms the right of every qualified applicant to receive consideration for employment without regard to race, color, religion, sex, gender identity or expression, national origin, sexual orientation, genetic information, disability, age, ancestry, military service, protected veteran status, or other characteristics protected by law.

.

Pay Transparency Statement

The hiring range is based on market pay structures, with individual salaries determined by factors such as business needs, market conditions, internal equity, and based on the candidate’s relevant experience, skills and qualifications.

For union positions, the pay range is determined by the Collective Bargaining Agreement (CBA).

$158,200.00 - $170,000.00